Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Geurts BS, Battaglia TW, van Berge Henegouwen JM, Zeverijn LJ, de Wit GF, Hoes LR, van der Wijngaart H, van der Noort V, Roepman P, de Leng WWJ, Jansen AML, Opdam FL, de Jonge MJA, Cirkel GA, Labots M, Hoeben A, Kerver ED, Bins AD, Erdkamp FGL, van Rooijen JM, Houtsma D, Hendriks MP, de Groot JB, Verheul HMW, Gelderblom H, Voest EE. Geurts BS, et al. Among authors: opdam fl. BMC Cancer. 2023 Mar 4;23(1):205. doi: 10.1186/s12885-023-10663-2. BMC Cancer. 2023. PMID: 36870947 Free PMC article.
SNPs and haplotypes in DPYD and outcome of capecitabine--Letter.
Opdam FL, Swen JJ, Wessels JA, Gelderblom H. Opdam FL, et al. Clin Cancer Res. 2011 Sep 1;17(17):5833-4; author reply 5835-6. doi: 10.1158/1078-0432.CCR-11-1208. Epub 2011 Aug 30. Clin Cancer Res. 2011. PMID: 21878541 No abstract available.
Phenotyping drug disposition in oncology.
Opdam FL, Gelderblom H, Guchelaar HJ. Opdam FL, et al. Cancer Treat Rev. 2012 Oct;38(6):715-25. doi: 10.1016/j.ctrv.2011.12.003. Epub 2012 Jan 4. Cancer Treat Rev. 2012. PMID: 22226243 Review.
The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.
Opdam FL, Dezentje VO, den Hartigh J, Modak AS, Vree R, Batman E, Smorenburg CH, Nortier JW, Gelderblom H, Guchelaar HJ. Opdam FL, et al. Cancer Chemother Pharmacol. 2013 Mar;71(3):593-601. doi: 10.1007/s00280-012-2034-4. Epub 2012 Dec 11. Cancer Chemother Pharmacol. 2013. PMID: 23228987
Breath tests to phenotype drug disposition in oncology.
Opdam FL, Modak AS, Gelderblom H, Guchelaar HJ. Opdam FL, et al. Clin Pharmacokinet. 2013 Nov;52(11):919-26. doi: 10.1007/s40262-013-0099-9. Clin Pharmacokinet. 2013. PMID: 23868281 Review.
Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions.
Schutte T, Zeverijn LJ, Geurts BS, de Wit GF, Kok M, Opdam FL. Schutte T, et al. Among authors: opdam fl. Oncologist. 2023 Jul 5;28(7):e493-e497. doi: 10.1093/oncolo/oyad092. Oncologist. 2023. PMID: 37086483 Free PMC article.
Emphasizing the value of phenotyping in patients receiving tamoxifen.
Opdam FL, Dezentje VO, den Hartigh J, Guchelaar HJ, Gelderblom H. Opdam FL, et al. J Clin Oncol. 2012 Feb 1;30(4):464; author reply 465. doi: 10.1200/JCO.2011.38.8892. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184383 No abstract available.
41 results